调节性T细胞在自身免疫系统中的作用
摘要
免疫系统的稳态控制对机体至关重要。1970年代,就发现了一种具有免疫抑制性质的T细胞一调节性T细胞(regulatory Tcell,Treg),近年来成了免疫学领域研究的热点。现就调节性T细胞(Treg)在自身免疫系统中作用的相关文献作一综述。
出处
《浙江临床医学》
2009年第6期637-640,共4页
Zhejiang Clinical Medical Journal
参考文献26
-
1Sakaguchi S. Naturally arising Foxp3 - experessing CD4+ CD25+ regulatory T - cells in immunological tolerance to self. Nat Immuno1,2005, 699(4) :345-352.
-
2Liu W. Putnam AL, Xu - Yu Z, et al. CD127 expressing inversely correlates with Foxp3 and suppressive function of human CD4+ Treg cells. J EXP Med,2006,203(7) :1701 - 1711.
-
3Groux H O, Garra A, Bigler M, et al. A CD4+ T - cell subset inhibits antigenspecific T- cell responses and prevents colitis. Nature, 1997, 3899 (6652) :737 - 742.
-
4Faria A M, Weiner H L. Oral tolerance, Immunol Rev,2005,206:232 - 259.
-
5Balandina A,Lecart S,Dartevelle P, et al. Functional defect of regulatory CD4+ CD2+ T - cells in the thymus of patients with autoimmune myasthenia gravis. Blood, 2005,105:735 - 741.
-
6Ermann J, Szanya V, Ford GS, et al. CD4^+ CD25^ T - cells facilitate the induction of T cell anergy. J J Immunol,2001,167 (8) :4271 - 4275.
-
7Kukreja A, Cost G, Marker J, et al. Multiple immuno - regulatory defects in typel diabetes. J Clin Invest. 2002,6109:131 - 140.
-
8RognerUC,Lepauh F, GagnerauhMC, et al. The diabetes type 1 locus Idd6 modulates activity of CD4^+ CD25^regulatory T - cells. Diabetes, 2006,55:186 - 192.
-
9Crispin JC, Martines A,Alcocer Varela J, et al. Quantification of regulatory T - cells in patients with systemic lupus erythematosus. J Autoimmun ,2003 Nov,21 (3) :273 - 276.
-
10Vigna - Perez M, Hemandez - Castro B, Paredes - Saharopulos O,et al. Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy:pilot study. Arthritis Res Ther,2006,8 ( 3 ) : R83.
二级参考文献26
-
1Changlin Wu~(1,2) Fang Liu~1 Xuemin Zhou~1 Zhengwei Cheng~1 Xiaomeng Yang~1 Hong Xiao~1 Qun Chen~1 Kangrong Cai~1 ~1Department of Microbiology and Immunology,Guangdong Medical College,Zhanjiang,Guangdong,524023,China,~2Corresponding to:Dr.Changlin Wu,Department of Microbiology and Immunology,Guangdong Medical College,2 Wen-Ming East Road,Zhanjiang,Guangdong,524023,China..Effect of Protein Kinase C on Proliferation and Apoptosis of T Lymphocytes in Idiopathic Thrombocytopenic Purpura Children[J].Cellular & Molecular Immunology,2005,2(3):197-203. 被引量:12
-
2Hafler D A, Slavik J M, Anderson D E et al. Multiple sclerosis [J]. Immunol Rev, 2005 ; 204 : 208-231.
-
3Hemmer B, Cepok S, Nessler Set al. Pathogenesis of multiple sclerosis: an update on immunology [ J]. Curr Opin Neurol, 2002; 15 (3) : 227-231.
-
4Prat A, Antel J. Pathogenesis of multiple sclerosis [ J ]. Curr Opin Neurol, 2005; 18(3) : 225-230.
-
5Viglietta V, Baecher-Allan C, Weiner H Let al. Loss of functional suppression by CD4^ + CD25^ + regulatory T cells in patients with multipie sclerosis [ J ]. J Exp Med, 2004 : 199 (7) :971-979.
-
6Haas J, Hug A, Viehover A et al. Reduced suppressive effect of (CD4^ + ) CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis[ J]. Eur J Immunol, 2005 ; 35 ( 11 ) :3343-3352.
-
7Putheti P, Pettersson A, Soderstrom Met al. Circulating CD4^ + CD25^ + T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs [ J]. J Clin Immunol, 2004; 24 (2) :155-161.
-
8Feger U, Luther C, Poeschel S et al. Increased frequency of CD4^ + CD25^ + regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients [ J ]. Clin Exp Immunol, 2007 ; 147 (3) :412-418.
-
9Zheng G, Wang B, Chen A et al. The 4-1BB costimulation augments the proliferation of CD4^ + CD25^+ regulatory T cells [ J]. J Immunol, 2004 : 173 (4) :2428-2434.
-
10Choi B K, Bae J S, Choi E M et al. 4-1BB-dependent inhibition of immunosuppression by activated CD4 ^+ CD25 ^+ T cells [ J]. J Leukoc Biol, 2004:75 (5) :785-791.
共引文献6
-
1伍昌林,薛俭成,党鑫堂.ITP患儿外周血T细胞T-bet/GATA-3基因的检测及意义[J].中国小儿血液与肿瘤杂志,2009,14(5):201-203.
-
2侯娟.多发性硬化免疫机制研究新进展[J].国际免疫学杂志,2009,32(6):468-471. 被引量:2
-
3董毅,刘蕾,张飞虎,汤继春,夏瑞祥,曾庆曙.环孢素联合达那唑对糖皮质激素无效或依赖的特发性血小板减少性紫癜患者疗效分析[J].中国医药,2011,6(1):83-84. 被引量:10
-
4樊宁,孙福生.免疫学检验方法的进展和应用[J].医学综述,2011,17(7):1063-1066. 被引量:1
-
5孙蕊芸,余惠平,乔俊艳,董玢,刘书方,范小莉,谢欢来.“鸡尾酒”疗法治疗持续及慢性ITP儿童患者22例[J].辽宁中医药大学学报,2017,19(3):146-149. 被引量:3
-
6陈昊,袁野,任一文,周攀.T淋巴细胞在原发免疫性血小板减少症发病机制中的作用[J].中国医药科学,2022,12(23):47-49. 被引量:2
-
1徐丽玲,胡凡磊,苏茵.分泌颗粒酶B的调节性B细胞研究进展[J].中华风湿病学杂志,2016,20(8):564-566. 被引量:2
-
2左晓霞.结缔组织病与感染[J].实用医院临床杂志,2011,8(2):29-31. 被引量:3
-
3袁小燕.系统性红斑狼疮合并自身免疫性溶血性贫血的临床分析[J].实用临床医药杂志,2007,11(2):98-98. 被引量:5
-
4余志辉,黎艳湘.抗CCP RF IgG C3 C4诊断类风湿关节炎的效果观察[J].中国实用乡村医生杂志,2014(12):30-31.
-
5新动态[J].糖尿病新世界,2012(5):6-7.
-
6孙雨梅,张彦明,何广胜,陆沭华,韩雪花,崔红霞.CD4^+CD25^+调节性T细胞在特发性血小板减少性紫癜患者中的变化及意义[J].临床血液学杂志,2008,21(5):469-470. 被引量:11
-
7郑明华,陈永平,张友才,辛永宁.CD4^+CD25^+T_(reg)细胞在人类疾病中的研究进展[J].医学研究杂志,2007,36(11):101-103. 被引量:1
-
8新发现[J].糖尿病新世界,2011(5):14-14.
-
9张玉麟.心理压力背后的都市症--红斑狼疮记述[J].现代中医药(北京),2005(3):21-23.
-
10赵冰,赵辉,王群,邵李海,王博,张鹏飞.自身抗体在自身免疫性肝病中的表达及临床价值[J].中国冶金工业医学杂志,2010,27(6):680-681.